Intelligence Platform

Patents

Browse 17 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 12343350

Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AH

Windtree Therapeutics, Inc. · Granted Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12295929

Intravenous baclofen formulations and treatment methods

Regents of the University of Minnesota · Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12146150

Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intraven

VOYAGER THERAPEUTICS, INC. · Granted Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11583540

Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AH

Windtree Therapeutics, Inc. · Granted Tue Feb 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11197869

Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AH

Windtree Therapeutics, Inc. · Granted Tue Dec 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10933042

Intravenous baclofen formulations and treatment methods

Regents of the University of Minnesota · Granted Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10350183

Intravenous baclofen formulations and treatment methods

Regents of the University of Minnesota · Granted Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10010534

Intravenous formulation and LC/MS/MS analysis method for GMC1

The Board of Regents of the University of Texas System · Granted Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9931311

Treating critically ill patients with intravenous ibuprofen

Cumberland Pharmaceuticals Inc. · Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9675572

Intravenous omega-3 fatty acid compositions and method of use

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9649284

Treating critically ill patients with intravenous ibuprofen

Cumberland Pharmaceuticals Inc. · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9295639

Treating critically ill patients with intravenous ibuprofen

Cumberland Pharmaceuticals Inc. · Granted Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9138404

Treating critically ill patients with intravenous ibuprofen

Cumberland Pharmaceuticals Inc. · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9114068

Treating patients with intravenous ibuprofen

Cumberland Pharmaceuticals Inc. · Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9012508

Administration of intravenous ibuprofen

Cumberland Pharmaceuticals Inc. · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8871810

Treating critically ill patients with intravenous ibuprofen

Cumberland Pharmaceuticals Inc. · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8735452

Treating patients with intravenous ibuprofen

Cumberland Pharmaceuticals Inc. · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted